This course may contain imagery and/or video of surgical procedures.
The field of pediatric pancreatology has evolved significantly over the past decade, growing from a diagnosis with no clear criteria, prognosis, or therapy to a subspecialty with evidence-based, multidisciplinary treatment programs. Children with acute and chronic pancreatitis are vastly different from adults and require focused pediatric care to improve diagnostic efficiency and therapeutic outcomes. Collaboration among multiple specialties, including the general pediatrician, gastroenterology, nutrition, radiology, surgery, endocrinology, and genetics is the foundation for an evidence-based, standardized approach. This session, composed of quick bites and cases from experts from one of the largest pediatric pancreas programs in the country, will provide the general pediatrician and pediatric gastroenterologist with the most up-to-date, evidence-based approaches to diagnosis and management of pediatric pancreatitis.
- Describe how to accurately diagnose acute, recurrent, and chronic pancreatitis in pediatric patients
- Explain the different approaches to short- and long-term therapies in pediatric pancreatitis
- Explain the evidence-based pathways for identifying which patients would be appropriate candidates for surgical or interventional procedures to treat complex pediatric pancreatitis
- Asim Maqbool, MD
- Jefferson N. Brownell, MD, MS
- Sudha A. Anupindi, MD, FSAR
- Erica Schwab, RD, LDN
- Sarah Mayer-Brown, PhD
- Diana Stanescu, MD
- Pablo Laje, MD
This seminar focuses on gastroenterology and was delivered at a virtual event titled, “Acute vs. Chronic Pancreatitis: Diagnosis, Dilemmas and Management,” on October 28, 2020.
- View our clinical pathway for Emergency Department and Inpatient Clinical Pathway for Treatment and Management of Non-Traumatic Pancreatitis.
- View our clinical pathway for ICU, Inpatient, Outpatient Specialty Care and Primary Care Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI).
Additional CHOP Resources:
The work presented in the presentations, videos, and other content on this site (“Presentations”) includes publicly available medical evidence, a consensus of medical practitioners, and/or opinions of individual practitioners that may differ from consensus opinions. These Presentations are intended only to provide general information and need to be adapted for each specific patient based on the practitioner’s professional judgment, consideration of any unique circumstances, the needs of each patient and their family, the availability of various resources at the health care institution where the patient is located, and other factors. The Presentations are not intended to constitute medical advice or treatment, nor should they be relied upon as such. The Presentations are not intended to create a doctor-patient relationship between/among The Children’s Hospital of Philadelphia, its physicians and the individual patients in question. The information contained in these Presentations are general in nature, and do not and are not intended to refer to specific patients.
CHOP, The Children’s Hospital of Philadelphia Foundation and its or their affiliates, the authors, presenters, practitioners, editors, and others associated with the creation of the Presentations (“CHOP”) are not responsible for errors or omissions in the Presentations; for any outcomes a patient might experience where a clinician reviewed one or more such Presentations in connection with providing care for that patient; and/or for any and all third party content on the site or in the Presentations. CHOP makes no warranty, expressed or implied, with respect to the currency, completeness, applicability or accuracy of the Presentations. Application of the information in or to a particular situation remains the professional responsibility of the practitioner who is directly treating the patient.
To the extent that the Presentations include information regarding drug dosing, in view of ongoing research, changes in government regulations and the constant flow of information relating to drug therapy and drug reactions, the viewer should not rely on the Presentation content, but rather is urged to check the package insert for each drug for indications, dosage, warnings and precautions.
Some drugs and medical devices presented in the Presentations have United States Food and Drug Administration (FDA) clearance for limited use in restricted research settings. It is the responsibility of the practitioner to ascertain the FDA status of each drug or device planned for use in their clinical practice.
You shall indemnify, defend and hold harmless CHOP, The Children’s Hospital of Philadelphia Foundation, and its/their current and former employees, officers, and agents, trustees, and their respective successors, heirs and assigns (“Indemnitees”) against any claims, liability, damage, loss or expenses (including attorneys’ fees and expenses of litigation) in connection with any claims, suits, actions, demands or judgments arising directly or indirectly out of your reference to or use of the Presentations.
The Presentations are protected by copyright laws and in some cases patent laws, and all rights are reserved under such laws. No part of the Presentations may be reproduced in any form by any means, or utilized in any other way, absent prior written permission from the copyright owner.
By starting this module, you agree to our Content Disclaimer and Terms of Service.